SFRS17A Antibodies

Santa Cruz Biotechnology delivers a wide array of SFRS17A monoclonal antibodies for investigating SFRS17A's role in cellular processes. SFRS17A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SFRS17A, also known as splicing factor, arginine/serine-rich 17A, plays a critical role in pre-mRNA splicing and gene expression regulation. Alternative splicing mechanisms regulated by SFRS17A are essential for producing diverse protein isoforms, which influence numerous biological pathways. Research has shown that SFRS17A dysfunction may contribute to various pathological conditions. Understanding SFRS17A's molecular mechanisms and regulatory functions can provide valuable insights into potential therapeutic strategies. Ongoing studies continue to reveal new aspects of SFRS17A's biological significance and disease associations. Current investigations focus on understanding how SFRS17A influences RNA processing and cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SFRS17A's role in health and disease.